Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
M Merchant, J Moffat, G Schaefer, J Chan, X Wang… - PloS one, 2017 - journals.plos.org
… RAS mutant models but only additive in BRAF mutant models where the RAF complex is
dissociated from RAS … We discovered that pathway reactivation in RAS mutant models occurs at …
dissociated from RAS … We discovered that pathway reactivation in RAS mutant models occurs at …
SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors
H Lu, C Liu, R Velazquez, H Wang, LM Dunkl… - Molecular cancer …, 2019 - AACR
… Taken together, we speculate that the pathway reactivation in KRAS-mutant cell lines may
… mutant-specific RAS antibodies, we performed the RAS activation assays with homozygous …
… mutant-specific RAS antibodies, we performed the RAS activation assays with homozygous …
Targeting the MAPK pathway in RAS mutant cancers
SG Hymowitz, S Malek - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
… mutant tumors and, over time, results in pathway reactivation … Multiple studies have shown
that this pathway reactivation is … robust efficacy in KRAS mutant tumors (Hatzivassiliou et al. …
that this pathway reactivation is … robust efficacy in KRAS mutant tumors (Hatzivassiliou et al. …
Therapeutic strategies to target RAS-mutant cancers
MB Ryan, RB Corcoran - Nature reviews Clinical oncology, 2018 - nature.com
… with a combination of a MEK inhibitor (AZD6244 or trametinib) and the ERK inhibitor VTX-11e
overcame pathway reactivation and was more effective than either agent alone in NRAS-…
overcame pathway reactivation and was more effective than either agent alone in NRAS-…
Targeting RAS-mutant cancers: is ERK the key?
The three RAS genes comprise the most frequently mutated oncogene family in cancer. With
… of mutant RAS is required for tumor maintenance, it is widely accepted that effective anti-…
… of mutant RAS is required for tumor maintenance, it is widely accepted that effective anti-…
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
RB Corcoran, H Ebi, AB Turke, EM Coffee, M Nishino… - Cancer discovery, 2012 - AACR
… We found that EGFR-mediated MAPK pathway reactivation leads to … BRAF-mutant colorectal
cancer cells, we investigated whether activation of RAS could account for the reactivation of …
cancer cells, we investigated whether activation of RAS could account for the reactivation of …
RAS, wanted dead or alive: Advances in targeting RAS mutant cancers
CA Stalnecker, CJ Der - Science signaling, 2020 - science.org
… like those of BRAF inhibitors, where pathway reactivation occurs through the up-regulation …
, and binimetinib, can aid in preventing pathway reactivation that leads to the activation of …
, and binimetinib, can aid in preventing pathway reactivation that leads to the activation of …
… Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation
… -mutant … reactivation of ERK-dependent signaling to bypass KRAS G12C blockade (4). Prior
work by our group and others has identified adaptive RAS pathway feedback reactivation as …
work by our group and others has identified adaptive RAS pathway feedback reactivation as …
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
B Delire, P Stärkel - European journal of clinical investigation, 2015 - Wiley Online Library
… deregulation of the Ras pathway in liver cancer. Ras and Raf gene mutations are rare events
… Hep3B cells with a DNA methylation inhibitor reactivates RASSF1A gene transcription 61. …
… Hep3B cells with a DNA methylation inhibitor reactivates RASSF1A gene transcription 61. …
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling
B Sanchez-Laorden, A Viros, MR Girotti… - Science …, 2014 - science.org
… in RAS mutant tumors To investigate the consequences of BRAF inhibition in RAS mutant
tumors… Our data have clear clinical implications because reactivation of the RAF-ERK pathway …
tumors… Our data have clear clinical implications because reactivation of the RAF-ERK pathway …
相关搜索
- mapk pathway ras mutant cancers
- combined mek ras mutant tumors
- renewed battle ras mutant cancers
- therapeutic strategies ras mutant cancers
- kras mutant cancers
- mutations in cancer ras isoforms
- ras mutants reasons for hope
- ras mutant mek and erk
- braf mutated cancers
- mek inhibition kras mutant cancer cells
- erk inhibition ras mutant tumors
- shp2 inhibition pathway reactivation
- antitumor activity mutant tumors
- ras mutant melanoma cells
- kras mutant pathway reactivation
- combined mek pathway reactivation